![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » VisiJet Completes $4.9 Million Financing
VisiJet Completes $4.9 Million Financing
February 3, 2005
VisiJet, a developer of innovative technologies for the ophthalmic surgical market, has closed on a financing of $4.9 million. VisiJet plans to use the funds to support marketing and sales of its lead product, the EpiLift System, and to improve its short-term debt structure. The EpiLift System is a new, safer refractive surgery technique that enables ophthalmologists to perform EpiLASIK surgery with fewer postoperative complications than existing methods.
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct